Cansortium Inc. (OTCMKTS:CNTMF) Sees Significant Increase in Short Interest

Cansortium Inc. (OTCMKTS:CNTMF) was the target of a large increase in short interest in the month of April. As of April 30th, there was short interest totaling 32,199 shares, an increase of 991.1% from the April 15th total of 2,951 shares. Based on an average daily trading volume, of 1,114,429 shares, the days-to-cover ratio is currently 0.0 days.

Cansortium Stock Up 2.1%

Shares of CNTMF stock opened at $0.02 on Thursday. The stock has a 50 day simple moving average of $0.03 and a 200-day simple moving average of $0.04. Cansortium has a 1-year low of $0.02 and a 1-year high of $0.09.

Cansortium (OTCMKTS:CNTMF) last announced its earnings results on Thursday, April 30th. The company reported ($0.16) earnings per share for the quarter. During the same period last year, the business earned ($0.14) earnings per share.

Cansortium Company Profile

Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.